Empirical Financial Services, LLC d.b.a. Empirical Wealth Management
Position in PTCT — Ptc Therapeutics, Inc.
CIK 1510434
Seattle, WA
Position in PTCT
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,298,267
+$354,600 QoQ
Shares Held
15,916
+14.9% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#162
of 380 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empirical Financial Services, LLC d.b.a. Empirical Wealth Management holds $12,687,043 across 17 Biotechnology names. PTCT ranks #5 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 73,041 | $2,295,678 | |||
| 2 | INBX |
Inhibrx Biosciences, Inc.
|
22,584 | $2,139,834 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
19,312 | $1,837,923 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
7,464 | $1,798,599 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
This page
|
15,916 | $1,298,267 | |
| 6 | EXEL |
Exelixis, Inc.
|
10,083 | $548,615 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
11,831 | $430,766 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
15,489 | $391,871 |
All Filings in PTCT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,298,267 | 15,916 | Shares | Other | 2026-07-15 | |
| 2026-03-31 | $943,667 | 13,851 | Shares | Other | 2026-05-04 | |
| 2025-12-31 | $959,678 | 12,634 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $1,274,961 | 20,775 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||